MicroTech Medical (Hangzhou) Future Growth
Future criteria checks 5/6
MicroTech Medical (Hangzhou) is forecast to grow earnings and revenue by 87.2% and 34% per annum respectively while EPS is expected to grow by 87% per annum.
Key information
87.2%
Earnings growth rate
87.0%
EPS growth rate
| Medical Equipment earnings growth | 33.2% |
| Revenue growth rate | 34.0% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 18 Apr 2024 |
Recent future growth updates
Recent updates
MicroTech Medical (Hangzhou) (HKG:2235) Is In A Good Position To Deliver On Growth Plans
Sep 22
News Flash: One MicroTech Medical (Hangzhou) Co., Ltd. (HKG:2235) Analyst Has Been Trimming Their Revenue Forecasts
Jan 20MicroTech Medical (Hangzhou) (HKG:2235) Is In A Good Position To Deliver On Growth Plans
Jan 18Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 730 | 46 | N/A | N/A | 1 |
| 12/31/2025 | 539 | -13 | N/A | N/A | 1 |
| 12/31/2024 | 366 | -83 | N/A | N/A | 1 |
| 12/31/2023 | 253 | -125 | N/A | N/A | N/A |
| 9/30/2023 | 233 | -85 | N/A | N/A | N/A |
| 6/30/2023 | 213 | -46 | -133 | -113 | N/A |
| 3/31/2023 | 193 | -40 | -135 | -110 | N/A |
| 12/31/2022 | 174 | -35 | -137 | -108 | N/A |
| 9/30/2022 | 169 | -36 | -112 | -84 | N/A |
| 6/30/2022 | 164 | -37 | -87 | -61 | N/A |
| 3/31/2022 | 158 | -43 | -75 | -53 | N/A |
| 12/31/2021 | 151 | -48 | -63 | -44 | N/A |
| 12/31/2020 | 75 | -121 | -35 | -10 | N/A |
| 12/31/2019 | 52 | -79 | -48 | -18 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2235 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).
Earnings vs Market: 2235 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 2235 is expected to become profitable in the next 3 years.
Revenue vs Market: 2235's revenue (34% per year) is forecast to grow faster than the Hong Kong market (7.7% per year).
High Growth Revenue: 2235's revenue (34% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 2235's Return on Equity is forecast to be high in 3 years time